Verona Pharma Announces US FDA Approval of Ohtuvayre™ (ensifentrine)
June 26, 2024 16:57 ET
|
Verona Pharma plc
Verona Pharma announces the FDA approved Ohtuvayre (ensifentrine) for the maintenance treatment of COPD in adult patients.
Fennec Announces Results of Annual Meeting
June 25, 2024 16:35 ET
|
Fennec Pharmaceuticals Inc.
Annual meeting voting results.
Humacyte Presents Positive Preclinical Data For Its BioVascular Pancreas (BVP™) Program
June 25, 2024 08:00 ET
|
Humacyte, Inc
– BioVascular Pancreas (BVP) product candidate is under development as a potential treatment for type 1 diabetes – – Humacyte’s stem cell-derived islets observed to restore normal blood glucose...
GeneType Identifies 79.5% of People Tested are at Risk of Serious Disease
June 25, 2024 08:00 ET
|
Genetic Technologies Ltd
GeneType Identifies 79.5% of People Tested are at Risk of Serious Disease
vTv Therapeutics Announces Screening of First Patient in CATT1 Pivotal Trial Evaluating Cadisegliatin for Type 1 Diabetes
June 24, 2024 16:05 ET
|
vTv Therapeutics Inc.
Cadisegliatin is a potential first-in-class oral liver selective glucokinase activator for T1D, which has been granted Breakthrough Therapy designation by the FDA for T1D Cadisegliatin has been dosed...
G1 Therapeutics Provides Update on Phase 3 PRESERVE 2 Trial in Patients Receiving Trilaciclib Prior to First Line Chemotherapy in Metastatic Triple Negative Breast Cancer (mTNBC)
June 24, 2024 06:30 ET
|
G1 Therapeutics
G1 Therapeutics Provides Update on Phase 3 PRESERVE 2 Trial in Patients Receiving Trilaciclib Prior to First Line Chemotherapy in Metastatic Triple Negativ
Join Genetic Technologies’ Exclusive Live Investor Webinar and Q&A Session on June 27
June 21, 2024 08:00 ET
|
Genetic Technologies Ltd
Join Genetic Technologies’ Exclusive Live Investor Webinar and Q&A Session on June 27
Fortrea to Participate in Virtual Fireside Chat with Evercore ISI
June 19, 2024 17:02 ET
|
Fortrea Holdings Inc
DURHAM, N.C., June 19, 2024 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE), a leading global contract research organization (CRO), today announced that Chief Financial Officer Jill McConnell will...
Kriya Appoints Katherine Eade as Chief Legal Officer
June 18, 2024 09:05 ET
|
Kriya Therapeutics, Inc.
PALO ALTO, Calif., and RESEARCH TRIANGLE PARK, N.C., June 18, 2024 (GLOBE NEWSWIRE) -- Kriya Therapeutics, Inc. ("Kriya"), a biopharmaceutical company developing gene therapies to address common...
Genetic Technologies Expands Operational Capacity in North America
June 18, 2024 08:00 ET
|
Genetic Technologies Ltd
GeneType Expands Operational Capacity in North America